For instance, a recent study developed a combinatorial therapy for glioblastoma based on iron oxide NPs (IONPs) co-loaded with siRNAs-targeting glutathione peroxidase 4 (si-GPX4) and cisplatin (Cs, platinum-based anticancer drug). Here, GPX4 is linked to glioblastoma.